Top Markets
#1 Official Trump Official Trump +57.45%
#2 Melania Meme Melania Meme +31.64%
#3 Mubarak Mubarak +27.35%
#4 EXOD EXOD +18.93%
#5 Wrapped POL Wrapped POL +18.46%
#6 POL (ex-MATIC) POL (ex-MATIC) +17.94%
#7 Wrapped STX (Velar) Wrapped STX (Velar) +17.66%
#8 Movement Movement +17.63%
#9 Verge Verge +15.15%
#10 Pearl Pearl +14.30%
Coin of the day
Official Trump Official Trump
Settings
Language
ENGLISH
Currency
USD
Theme
MindWalk Holdings Corp. MindWalk Holdings Corp.

MindWalk Holdings Corp.

HYFT
Rank in Stocks #24078
MindWalk Holdings Corp. functions as an innovative bio-native artificial... MindWalk Holdings Corp. functions as an innovative bio-native artificial intelligence firm. Its core mission involves leveraging the synergy of AI, comprehensive multi-omics data, and sophisticated laboratory investigations to accelerate the identification and advancement of biological therapeutics. Utilizing its proprietary LensAI platform and HYFT technology, the company forges partnerships with pharmaceutical and biotechnology enterprises. These collaborations are designed to diminish the inherent risks associated with drug development and to unlock new possibilities for treatments. Founded in 1983, the company adopted its current name, MindWalk Holdings Corp., in September 2025, having previously been known as ImmunoPrecise Antibodies Ltd. Its corporate headquarters are located in Austin, Texas.
Share Price
$1.39
Last synced: 2026-08-21
Market Cap
$65.31M
Change (1 day)
1.46%
Change (1 year)
-56.56%
Country
US
Trade MindWalk Holdings Corp. (HYFT)

Category

Healthcare
Revenue for MindWalk Holdings Corp. (HYFT)
Revenue in Aug 2026 TTM: 0
According to MindWalk Holdings Corp. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for MindWalk Holdings Corp. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH